242 related articles for article (PubMed ID: 17217681)
21. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
[TBL] [Abstract][Full Text] [Related]
22. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
23. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
24. [Effects of immune modulation therapy on cardiac function in aged patients with chronic heart failure].
Cao XJ; Li YF; Cao FF; Shi ST; Wang G; Zhang LJ; Liu F
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):734-8. PubMed ID: 21055143
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
[TBL] [Abstract][Full Text] [Related]
26. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
[TBL] [Abstract][Full Text] [Related]
27. Effects of bisoprolol in patients with stable congestive heart failure.
de Groote P; Delour P; Lamblin N; Dagorn J; Verkindère C; Tison E; Millaire A; Bauters C
Ann Cardiol Angeiol (Paris); 2004 Jul; 53(4):167-70. PubMed ID: 15369311
[TBL] [Abstract][Full Text] [Related]
28. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot.
Norozi K; Bahlmann J; Raab B; Alpers V; Arnhold JO; Kuehne T; Klimes K; Zoege M; Geyer S; Wessel A; Buchhorn R
Cardiol Young; 2007 Aug; 17(4):372-9. PubMed ID: 17572925
[TBL] [Abstract][Full Text] [Related]
29. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
30. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
Ohlin B; Berglund G; Nilsson PM; Melander O
J Hypertens; 2008 Aug; 26(8):1583-9. PubMed ID: 18622236
[TBL] [Abstract][Full Text] [Related]
31. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
[TBL] [Abstract][Full Text] [Related]
32. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
O'Shaughnessy KM; Fu B; Dickerson C; Thurston D; Brown MJ
Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
34. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
[TBL] [Abstract][Full Text] [Related]
35. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Chin BS; Gibbs CR; Blann AD; Lip GY
Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population.
Ramu P; Rajan S; Shewade DG; Swaminathan RP; Dutta TK; Balachander J; Adithan C
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):576-82. PubMed ID: 19673943
[TBL] [Abstract][Full Text] [Related]
37. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
[TBL] [Abstract][Full Text] [Related]
38. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
39. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
[TBL] [Abstract][Full Text] [Related]
40. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
